Publication | Open Access
First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor
73
Citations
28
References
2020
Year
www.ClinicalTrials.gov code: NCT01618136.
| Year | Citations | |
|---|---|---|
Page 1
Page 1